That's just the tip of the iceberg. All brokers will be downgrading based on that shocker. I was expecting a report that would at least support a share price that has bombed over 30% in 3 months, however, they couldn't even achieve that lowball expectation.
The only thing GXY has going for it at the moment is that it is currently so highly shorted that there's probably difficulty finding any more shares to short without going on a waiting list. Without that, it would have been in freefall today.
- Forums
- ASX - By Stock
- GXY
- Ann: Quarterly Report - March 2018
Ann: Quarterly Report - March 2018, page-164
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online